Evidence map›Paper›PMID 39008379›Full record

ArticleThe Journal of infectious diseases2025

Molecular Methods Enhance the Detection of Pyoderma-Related Streptococcus pyogenes and emm-Type Distribution in Children.

Jennifer N Hall, Edwin P Armitage, Elina Senghore, Saffiatou Darboe, Momodou Barry, Janko Camara, Sulayman Bah, Alexander J Keeley, James S McCarthy, Pierre Smeesters and 5 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Polish journal of microbiology · 2025
    Article
  4. Article
  5. Pertussis vaccines, epidemiology and evolution.Nature reviews. Microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jennifer N HallDivision of Clinical Medicine and National Institute for Health and Care Research Sheffield Biomedical Research Centre, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.ORCID 0009-0006-2608-569X
Edwin P ArmitageVaccines and Immunity Theme, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Banjul, The Gambia.ORCID 0000-0003-1125-4260
Elina SenghoreVaccines and Immunity Theme, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Saffiatou DarboeVaccines and Immunity Theme, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Banjul, The Gambia.ORCID 0000-0002-4711-3307
Momodou BarryVaccines and Immunity Theme, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Janko CamaraVaccines and Immunity Theme, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Sulayman BahVaccines and Immunity Theme, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Alexander J KeeleyDivision of Clinical Medicine and National Institute for Health and Care Research Sheffield Biomedical Research Centre, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0001-9386-1157
James S McCarthyPeter Doherty Institute of Infection and Immunity, University of Melbourne, Melbourne, Australia.
Pierre SmeestersDepartment of Paediatrics, Brussels University Hospital, Academic Children Hospital Queen Fabiola, Université libre de Bruxelles, Brussels, Belgium.ORCID 0000-0002-2642-9919
Claire E TurnerThe Florey Institute of Infection, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-4458-9748
Thomas C DartonDivision of Clinical Medicine and National Institute for Health and Care Research Sheffield Biomedical Research Centre, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0003-2209-9956
Michael MarksDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-7585-4743
Adrienn AngyalDivision of Clinical Medicine and National Institute for Health and Care Research Sheffield Biomedical Research Centre, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0001-8483-1749
Thushan I de SilvaDivision of Clinical Medicine and National Institute for Health and Care Research Sheffield Biomedical Research Centre, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-6498-9212

Funding

Higher Education Funding Council for EnglandNational Institute for Health and Care ResearchSheffield Biomedical Research Centre NIHR203321University of SheffieldWellcome TrustWellcome Trust Intermediate Clinical
6 · The paper itself

Abstract

backgroundStreptococcus pyogenes-related skin infections are increasingly implicated in the development of rheumatic heart disease (RHD) in lower-resource settings, where they are often associated with scabies. The true prevalence of S pyogenes-related pyoderma may be underestimated by bacterial culture.

methodsA multiplex quantitative polymerase chain reaction (qPCR) assay for S pyogenes, Staphylococcus aureus, and Sarcoptes scabiei was applied to 250 pyoderma swabs from a cross-sectional study of children aged <5 years in The Gambia. Direct PCR-based emm-typing was used to supplement previous whole genome sequencing (WGS) of cultured isolates.

resultsPyoderma lesions with S pyogenes increased from 51% (127/250) using culture to 80% (199/250) with qPCR. Compared to qPCR, the sensitivity of culture was 95.4% for S pyogenes (95% confidence interval {CI}, 77.2%-99.9%) in samples with S pyogenes alone (22/250 [9%]), but 59.9% (95% CI, 52.3%-67.2%) for samples with S aureus coinfection (177/250 [71%]). Direct PCR-based emm-typing was successful in 50% (46/92) of cases, identifying 27 emm-types, including 6 not identified by WGS (total 52 emm-types).

conclusionsBacterial culture significantly underestimates the burden of S pyogenes in pyoderma, particularly with S aureus coinfection. Molecular methods should be used to enhance the detection of S pyogenes in surveillance studies and clinical trials of preventive measures in RHD-endemic settings.

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsPyodermaStreptococcal InfectionsStreptococcus pyogenesChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleMultiplex Polymerase Chain ReactionPrevalenceScabiesSensitivity and SpecificityAntigens, BacterialBacterial Outer Membrane ProteinsCarrier Proteinsstreptococcal M proteinemm-typingPCRskin infectionstrain diversityStreptococcus pyogenes

Identifiers

PMID39008379
PMCPMC11793063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.